Cyclerion Therapeutics, Inc. Common Stock (CYCN) is a publicly traded Healthcare sector company. As of May 21, 2026, CYCN trades at $3.02 with a market cap of $13.08M and a P/E ratio of -2.27. CYCN moved +4.33% today. Year to date, CYCN is +123.19%; over the trailing twelve months it is -6.21%. Its 52-week range spans $1.03 to $9.47. Rallies surfaces CYCN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CYCN financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CYCN recently traded at $3.02. Market cap is $13.08M. P/E ratio is -2.27. Revenue is $1.99M.
| Metric | Value |
|---|---|
| Price | $3.02 |
| Market Cap | $13.08M |
| P/E Ratio | -2.27 |
| EPS | $-1.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.47 |
| 52-Week Low | $1.03 |
| Volume | 42 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.99M |
| Net Income | $-5.28M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.07M | $-3.53M | $-1.11 |
| 2024 | $2.00M | $-3.06M | $-1.21 |
| 2023 | $0 | $-5.26M | $-2.25 |
| 2022 | $1.63M | $-44.08M | $-1.01 |
CYCN analyst coverage data. Average price target: $0.00.